Clinical trial Recruiting at 1 site Observational Ages 18 to 18

Left bundle area pacing with Closed Loop Stimulation in dual‑chamber pacemakers

Official title: Observation of Clinical Routine Care for Patients Implanted With BIOTRONIK Devices Used for Conduction System Pacing (CSP) With Focus on Closed Loop Stimulation (CLS)

Run by Biotronik SE & Co. KG · NCT07608822 · Data updated 2026-11-12

This study tests whether a dual‑chamber pacemaker using left bundle area pacing and Closed Loop Stimulation can reduce device‑detected atrial fibrillation over 24 months in patients with sinus node disease and AV conduction issues.

Quick facts

Study typeObservational
Ages18 Years to 18 Years
SexAll
Enrollment150 (estimated)
SponsorBiotronik SE & Co. KG
Industry-sponsored
Locations12 sites (Ústí nad Labem and 11 other locations)
StatusRecruiting
StartedMay 29, 2026
Main results expectedMay 29, 2028
Study endsMay 29, 2030
Registry record updatedJuly 17, 2026
Trial IDNCT07608822 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Patients with sinus node dysfunction and concomitant AV conduction disorders, indicated for standard dual‑chamber pacing with DDD‑CLS mode activated.

Probably not a fit

Patients without device‑detected AF or without improvement in rhythm management may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational submodule of the BIO|STREAM.CSP registry. It collects real‑world data on BIOTRONIK dual‑chamber pacemakers that use left bundle area pacing in combination with Closed Loop Stimulation. The study looks at the incidence of device‑detected atrial fibrillation over 24 months and how CLS adjusts pacing rates when the ventricular lead sits in the conduction system. It also aims to characterize the physiological pacing behavior and safety in routine clinical practice. Eligible patients have sinus node disease with AV conduction disorders and meet standard dual‑chamber pacing indications.

Why it matters

Potential benefit: If successful, the approach could reduce atrial fibrillation burden and improve rhythm management for patients needing dual‑chamber pacing.

How similar studies have gone: Other CSP and CLS studies have shown promise for more physiological pacing, but the specific LBBAP+CLS combination in a real‑world registry is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Enrolled in the BIO\|STREAM.CSP registry
* Standard indication for dual-chamber pacing due to any form of sinus node disease according to guidelines
* DDD-CLS pacing mode activated
* Either ≥ II degree AV block, or native PR interval ≥ 200 ms at baseline ECG with expected RVP ≥ 20%

Exclusion Criteria:

* Implantation dates back more than 90 days
* History of clinical AF
* Patients intended to receive, or already received a pacing lead for traditional RV pacing, His bundle pacing or right bundle branch pacing
* Upgrade from previous pacemaker system
* Patients transitioning from the BIO\|MASTER.CSP study
* DDAF episodes present in the device memory at the time of registration

Where it's running

  • A.O.U. Maggiore della Carita di Novara
    Novara, Italy
    Recruiting
  • Masarykova nemocnice v Usti nad Labem
    Ústí nad Labem, Czechia
    Not yet recruiting
  • Semmelweis University
    Budapest, Hungary
    Not yet recruiting
  • University of Szeged
    Szeged, Hungary
    Not yet recruiting
  • Ospedale Di Summa - Perrino
    Brindisi, Italy
    Not yet recruiting
  • Niguarda hospital
    Milan, Italy
    Not yet recruiting
Show 6 more locations
  • Ospedale di Piove di Sacco
    Piove di Sacco, Italy
    Not yet recruiting
  • Fondazione Policlinico Universitario "Agostino Gemelli" Università Cattolica del Sacro Cuore
    Roma, Italy
    Not yet recruiting
  • SS Annunziata Taranto
    Taranto, Italy
    Not yet recruiting
  • Unidade local de Saúde de Coimbra, EPE - Centro Hospitalar Universitario de Coimbra
    Coimbra, Portugal
    Not yet recruiting
  • Hospital Universitario 12 de Octubre
    Madrid, Spain
    Not yet recruiting
  • Hospital Universitario La Fe
    Valencia, Spain
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.